- Home
- RBKB vs DERM Comparison
RBKB vs DERM Comparison
Compare RBKB & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBKB
- DERM
- Stock Information
- Founded
- RBKB 1860
- DERM 2014
- Country
- RBKB United States
- DERM United States
- Employees
- RBKB N/A
- DERM N/A
- Industry
- RBKB Banks
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- RBKB Finance
- DERM Health Care
- Exchange
- RBKB Nasdaq
- DERM Nasdaq
- Market Cap
- RBKB 111.3M
- DERM 107.4M
- IPO Year
- RBKB 2019
- DERM 2021
- Fundamental
- Price
- RBKB $10.31
- DERM $5.34
- Analyst Decision
- RBKB
- DERM Strong Buy
- Analyst Count
- RBKB 0
- DERM 2
- Target Price
- RBKB N/A
- DERM $10.00
- AVG Volume (30 Days)
- RBKB 6.1K
- DERM 51.2K
- Earning Date
- RBKB 04-24-2025
- DERM 05-12-2025
- Dividend Yield
- RBKB N/A
- DERM N/A
- EPS Growth
- RBKB N/A
- DERM N/A
- EPS
- RBKB N/A
- DERM N/A
- Revenue
- RBKB $25,911,000.00
- DERM $57,771,000.00
- Revenue This Year
- RBKB N/A
- DERM N/A
- Revenue Next Year
- RBKB N/A
- DERM $36.49
- P/E Ratio
- RBKB N/A
- DERM N/A
- Revenue Growth
- RBKB N/A
- DERM N/A
- 52 Week Low
- RBKB $7.30
- DERM $2.85
- 52 Week High
- RBKB $10.49
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- RBKB 61.09
- DERM 56.65
- Support Level
- RBKB $10.10
- DERM $4.85
- Resistance Level
- RBKB $10.43
- DERM $5.33
- Average True Range (ATR)
- RBKB 0.11
- DERM 0.32
- MACD
- RBKB 0.01
- DERM -0.03
- Stochastic Oscillator
- RBKB 71.43
- DERM 41.48
About RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one- to four-family residential real estate loans, and to purchase investment securities.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.